Optimization, Immunological Evaluation, and Combination Study of Mincle-Dependent Self-Adjuvanted Anti-Tn Cancer Vaccines with an External Adjuvant
Journal of Medicinal Chemistry · 12.06.2025 · 68 (11) · 11648-11662
DOI: 10.1021/acs.jmedchem.5c00522 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 15.05.2025. Verfasst von Xiaohui Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, International …. Hauptthemen laut MEDLINE: Adjuvants, Immunologic, Cancer Vaccines, Lectins, C-Type, Membrane Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Guangdong Provincial Department of Science and Technology, National Key Research and Development Program of China, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
Nine Tn-based cancer vaccines were designed and synthesized using Mincle agonists as a carrier to elucidate the structure-immunogenicity relationships of Mincle-dependent vaccines. The Immunological evaluation showed that the immune response levels were significantly influenced by the acyl chains of trehalose, coupling site of antigen and carriers, antigen copy number, and coupling mode of acyl chains and trehalose. Notably, installing the antigen onto the lipid chains of the carrier could also effectively improve the immunogenicity. Among them, conjugate 9 showed the highest activity. In the presence of EcMPLA (TLR4 agonist) and aluminum hydroxide (Al), the immunological activity of conjugate 9 could further be improved and significantly inhibit tumor growth, prolonging the survival time of tumor-challenged mice. Survived mice also successfully rejected subsequent tumor attacks without any additional treatment. This work provides guidance for developing and applying self-adjuvanted cancer vaccines using Mincle agonists as both the carrier and "build-in" adjuvant.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, International Institute for Translational Chinese Medicine, Guangzhou University of…
- Chinese Medicine Guangdong Laboratory, Hengqin, Zhuhai, Guangdong 519031, China.
ORCID-Profile: Zhongqiu Liu, Xiang Luo, Guochao Liao
Förderung
- Guangdong Provincial Department of Science and Technology
- National Key Research and Development Program of China
- Basic and Applied Basic Research Foundation of Guangdong Province
- Guangdong Special Support Plan
- National Natural Science Foundation of China
- Industrialization Project of the Chinese Medicine Guangdong Laboratory
Zitieren
APA
Li, X., Lu, X., Zhang, J., Gao, L., Liang, R., Han, B., Ming, W., Liu, Z., Luo, X., & Liao, G. (2025). Optimization, Immunological Evaluation, and Combination Study of Mincle-Dependent Self-Adjuvanted Anti-Tn Cancer Vaccines with an External Adjuvant. Journal of Medicinal Chemistry, 68(11), 11648-11662. https://doi.org/10.1021/acs.jmedchem.5c00522
Vancouver
Li X, Lu X, Zhang J, Gao L, Liang R, Han B, et al. Optimization, Immunological Evaluation, and Combination Study of Mincle-Dependent Self-Adjuvanted Anti-Tn Cancer Vaccines with an External Adjuvant. Journal of Medicinal Chemistry. 2025;68(11):11648-11662. doi:10.1021/acs.jmedchem.5c00522
BibTeX
@article{Li2025,
author = {Li, Xiaohui and Lu, Xin and Zhang, Junsong and Gao, Lingqiang and Liang, Ruxin and Han, Boyi and Ming, Wenbo and Liu, Zhongqiu and Luo, Xiang and Liao, Guochao},
title = {Optimization, Immunological Evaluation, and Combination Study of Mincle-Dependent Self-Adjuvanted Anti-Tn Cancer Vaccines with an External Adjuvant},
journal = {Journal of Medicinal Chemistry},
year = {2025},
volume = {68},
number = {11},
pages = {11648--11662},
doi = {10.1021/acs.jmedchem.5c00522}
}
EUVIMED